The lung immuno-oncology prognostic score (LIPS-3): a prognostic classification of patients receiving first-line pembrolizumab for PD-L1 ≥ 50% advanced non-small-cell lung cancer.

Saved in:
Bibliographic Details
Title: The lung immuno-oncology prognostic score (LIPS-3): a prognostic classification of patients receiving first-line pembrolizumab for PD-L1 ≥ 50% advanced non-small-cell lung cancer.
Authors: Banna GL; Oncology Department, Portsmouth University Hospitals NHS Trust, Portsmouth, UK., Cortellini A; Department of Surgery and Cancer, Imperial College London, London, UK; Department of Biotechnology and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy. Electronic address: a.cortellini@imperial.ac.uk., Cortinovis DL; Medical Oncology, Ospedale San Gerardo, Monza, Italy., Tiseo M; Medical Oncology Unit, University Hospital of Parma, Parma, Italy; Department of Medicine and Surgery, University of Parma, Parma, Italy., Aerts JGJV; Department of Pulmonary Diseases, Erasmus Medical Center, Rotterdam, the Netherlands., Barbieri F; Department of Oncology and Hematology, Modena University Hospital, Modena, Italy., Giusti R; Medical Oncology, St. Andrea Hospital, Rome, Italy., Bria E; Comprehensive Cancer Center, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, Rome, Italy; Department of Translational Medicine and Surgery, Università Cattolica del Sacro Cuore, Rome, Italy., Grossi F; Medical Oncology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Pizzutilo P; Thoracic Oncology Unit, Clinical Cancer Center IRCCS Istituto Temorid 'Giovanni Paolo II', Bari, Italy., Berardi R; Oncology Clinic, Università Politecnica Delle Marche, Ospedali Riuniti Di Ancona, Ancona, Italy., Morabito A; Thoracic Medical Oncology, Istituto Nazionale Tumori 'Fondazione G Pascale', IRCCS, Napoli, Italy., Genova C; Lung Cancer Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Mazzoni F; Department of Oncology, Careggi University Hospital, Florence, Italy., Di Noia V; Medical Oncology, University Hospital of Foggia, Foggia, Italy., Signorelli D; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Gelibter A; Medical Oncology (B), Policlinico Umberto I, 'Sapienza' University of Rome, Rome, Italy., Macerelli M; Department of Oncology, University Hospital Santa Maria Della Misericordia, Udine, Italy., Rastelli F; Medical Oncology, Fermo Area Vasta 4, Fermo, Italy., Chiari R; Medical Oncology, Ospedali Riuniti Padova Sud 'Madre Teresa Di Calcutta', Monselice, Italy., Rocco D; Pneumo-Oncology Unit, Monaldi Hospital, Naples, Italy., Gori S; Oncology Unit, IRCCS Ospedale Sacro Cuore Don Calabria, Negrar di Valpolicella VR, Italy., De Tursi M; Department of Medical, Oral & Biotechnological Sciences University G. D'Annunzio, Chieti-Pescara, Chieti, Italy., Di Marino P; Clinical Oncology Unit, S.S. Annunziata Hospital, Chieti, Italy., Mansueto G; Medical Oncology, F. Spaziani Hospital, Frosinone, Italy., Zoratto F; Medical Oncology, Santa Maria Goretti Hospital, Latina, Italy., Filetti M; Medical Oncology, St. Andrea Hospital, Rome, Italy., Montrone M; Thoracic Oncology Unit, Clinical Cancer Center IRCCS Istituto Temorid 'Giovanni Paolo II', Bari, Italy., Citarella F; Medical Oncology, Campus Bio-Medico University, Rome, Italy., Marco R; Medical Oncology, Campus Bio-Medico University, Rome, Italy., Cantini L; Department of Pulmonary Diseases, Erasmus Medical Center, Rotterdam, the Netherlands; Oncology Clinic, Università Politecnica Delle Marche, Ospedali Riuniti Di Ancona, Ancona, Italy., Nigro O; Medical Oncology, ASST-Sette Laghi, Varese, Italy., D'Argento E; Comprehensive Cancer Center, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, Rome, Italy., Buti S; Medical Oncology Unit, University Hospital of Parma, Parma, Italy., Minuti G; Department of Oncology and Hematology, AUSL Romagna, Ravenna, Italy., Landi L; Department of Oncology and Hematology, AUSL Romagna, Ravenna, Italy., Guaitoli G; Department of Oncology and Hematology, Modena University Hospital, Modena, Italy., Lo Russo G; Medical Oncology (B), Policlinico Umberto I, 'Sapienza' University of Rome, Rome, Italy., De Toma A; Medical Oncology (B), Policlinico Umberto I, 'Sapienza' University of Rome, Rome, Italy., Donisi C; Medical Oncology Unit, University Hospital and University of Cagliari, Cagliari, Italy., Friedlaender A; Oncology Department, University Hospital of Geneva, Geneva, Switzerland., De Giglio A; Division of Medical Oncology, S.Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy., Metro G; Department of Medical Oncology, Santa Maria della Misericordia Hospital, Azienda Ospedaliera di Perugia, Perugia, Italy., Porzio G; Medical Oncology, St. Salvatore Hospital, L'Aquila, Italy., Ficorella C; Department of Biotechnology and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy; Medical Oncology, St. Salvatore Hospital, L'Aquila, Italy., Addeo A; Oncology Department, University Hospital of Geneva, Geneva, Switzerland.
Source: ESMO open [ESMO Open] 2021 Apr; Vol. 6 (2), pp. 100078. Date of Electronic Publication: 2021 Mar 16.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2059-7029
DOI:10.1016/j.esmoop.2021.100078